A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
Totus Medicines
Totus Medicines
Actuate Therapeutics Inc.
Ensem Therapeutics
Eli Lilly and Company
Novartis
Johns Hopkins University
National University Hospital, Singapore
AstraZeneca
Novartis
Novartis
Haihe Biopharma Co., Ltd.
Institut de Cancérologie de Lorraine
UNICANCER
Duke University
Celcuity Inc
Novartis
Novartis
Novartis